Works matching IS 00316970 AND DT 2024 AND VI 80 AND IP 4

Results: 15

Retraction Note: Graphical representation of network meta-analysis: an iconographic support to the complexity of multiple data comparisons.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 623, doi. 10.1007/s00228-024-03650-4

By:

De Vecchis, Renato;
Ariano, Carmelina;
Rigopoulos, Angelos;
Noutsias, Michel

Publication type:

Article

The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 519, doi. 10.1007/s00228-024-03628-2

By:

Lasala, Ruggero;
Romagnoli, Alessia;
Santoleri, Fiorenzo;
Isgrò, Valentina;
Confalonieri, Corrado;
Costantini, Alberto;
Enrico, Fiorenza;
Russo, Gianluca;
Polidori, Piera;
Di Paolo, Alessandra;
Malorgio, Francesco;
Beretta, Giordano;
Musicco, Felice

Publication type:

Article

Patterns of inappropriate prescribing and clinical characteristics in patients at admission to an acute care of the elderly unit.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 553, doi. 10.1007/s00228-024-03627-3

By:

Zuleta, Mónica;
San-José, Antonio;
Gozalo, Inés;
Sánchez-Arcilla, Margarita;
Carrizo, Gabriela;
Alvarado, Marcelo;
Pérez-Bocanegra, Carmen

Publication type:

Article

Association of the predicted free blood concentration of teicoplanin with the development of renal dysfunction.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 597, doi. 10.1007/s00228-024-03638-0

By:

Sugiyama, Kyohei;
Hirai, Keita;
Suyama, Yukako;
Furuya, Kento;
Ito, Kenta

Publication type:

Article

Remimazolam versus propofol for sedation in gastrointestinal endoscopy and colonoscopy within elderly patients: a meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 493, doi. 10.1007/s00228-024-03624-6

By:

Ahmer, Wania;
Imtiaz, Sahar;
Alam, Daniyal Muhammad;
Ahmed, Khadija;
Sajid, Barka;
Yousuf, Juvairia;
Asnani, Sunny;
Fahim, Muhammad Ahmed Ali;
Ali, Rahmeen;
Mansoor, Marium;
Safdar, Muhammad Talha;
Anjum, Muhammad Umair;
Hasanain, Muhammad;
Larik, Muhammad Omar

Publication type:

Article

Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 613, doi. 10.1007/s00228-024-03623-7

By:

Cai, Dabei;
Chen, Qianwen;
Mao, Lipeng;
Xiao, Tingting;
Wang, Yu;
Gu, Qingqing;
Wang, Qingjie;
Ji, Yuan;
Sun, Ling

Publication type:

Article

Comment on "Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study".

Published in:

2024

By:

Lai, Shih-Wei;
Hwang, Bing-Fang;
Liu, Chiu-Shong;
Liao, Kuan-Fu

Publication type:

Letter

Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 603, doi. 10.1007/s00228-024-03633-5

By:

Rodrigues, Daniela A.;
Herdeiro, Maria Teresa;
Mateos-Campos, Ramona;
Figueiras, Adolfo;
Roque, Fátima

Publication type:

Article

The relationship between use of SGLT2is and incidence of respiratory and infectious diseases and site-specific fractures: a meta-analysis based on 32 large RCTs.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 563, doi. 10.1007/s00228-024-03631-7

By:

Wang, Yueping;
Zhou, Xian

Publication type:

Article

Dabigatran-related serious medication errors: an analysis using data from VigiBase.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 589, doi. 10.1007/s00228-024-03629-1

By:

Zhang, Qingxia;
Ding, Qian;
Yue, Qun-Ying

Publication type:

Article

Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 545, doi. 10.1007/s00228-024-03622-8

By:

Alrabadi, Nasr;
Al-Nusair, Mohammed;
Haddad, Razan;
Alburie, Lama;
Mhaidat, Nizar;
Aljarrah, Mohamad;
Hamoudeh, Ayman

Publication type:

Article

Tofacitinib for the treatment of severe rare skin diseases: a narrative review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 481, doi. 10.1007/s00228-024-03621-9

By:

Luo, Fenglin;
Zhang, Yuanyuan;
Wang, Ping

Publication type:

Article

Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 505, doi. 10.1007/s00228-024-03620-w

By:

Yu, Zhuchen;
Xu, Fei;
Zou, Juntao

Publication type:

Article

Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 575, doi. 10.1007/s00228-024-03619-3

By:

Aceves-Gonzalez, Carlos;
Caro-Rojas, Angela;
Rey-Galindo, John A.;
Aristizabal-Ruiz, Luz;
Hernández-Cruz, Karen

Publication type:

Article

Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 529, doi. 10.1007/s00228-023-03609-x

By:

Das, Shampa;
Riccobene, Todd;
Carrothers, Timothy J.;
Wright, James G.;
MacPherson, Merran;
Cristinacce, Andrew;
McFadyen, Lynn;
Xie, Rujia;
Luckey, Alison;
Raber, Susan

Publication type:

Article